Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
OSE Immunotherapeutics SA (FR:OSE)
PARIS:OSE
RESEARCH TOOLSreports
OSE Immunotherapeutics SA (OSE) Stock Price & Analysis
3 Followers
OSE Stock Chart & Stats
Day’s Range€4.61 - €4.64
52-Week Range― - ―
Previous Close€4.76
Volume334.00
Average Volume (3M)N/A
Market Cap
€100.31M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Sep 26, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€12.50Price Target Upside169.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.02% Mutual Funds
0.00% Other Institutional Investors
99.98% Public Companies and
Individual Investors
OSE FAQ
What was OSE Immunotherapeutics SA’s price range in the past 12 months?
Currently, no data Available
What is OSE Immunotherapeutics SA’s market cap?
Currently, no data Available
When is OSE Immunotherapeutics SA’s upcoming earnings report date?
OSE Immunotherapeutics SA’s upcoming earnings report date is Sep 26, 2024 which is in 139 days.
How were OSE Immunotherapeutics SA’s earnings last quarter?
OSE Immunotherapeutics SA released its earnings results on Mar 27, 2024. The company reported -€0.539 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.539.
Is OSE Immunotherapeutics SA overvalued?
According to Wall Street analysts OSE Immunotherapeutics SA’s price is currently Undervalued.
Does OSE Immunotherapeutics SA pay dividends?
OSE Immunotherapeutics SA does not currently pay dividends.
What is OSE Immunotherapeutics SA’s EPS estimate?
OSE Immunotherapeutics SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OSE Immunotherapeutics SA have?
Currently, no data Available
What happened to OSE Immunotherapeutics SA’s price movement after its last earnings report?
OSE Immunotherapeutics SA reported an EPS of -€0.539 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.317%.
Which hedge fund is a major shareholder of OSE Immunotherapeutics SA?
Currently, no hedge funds are holding shares in FR:OSE
---
OSE Immunotherapeutics SA Stock Smart Score
Company Description
OSE Immunotherapeutics SA
OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.
---
OSE Stock 12 Month Forecast
Average Price Target
€12.50
▲(169.69% Upside)
Technical Analysis
Best Analysts Covering OSE
1 Year
1 Year Success Rate
8/14 ratings generated profit
1 Year Average Return
+4.49%
reiterated a buy rating 30 days ago
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +4.49% per trade.
---